In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org medical adviser, discusses some of the research that was published in September and October 2014.
Listen to the podcast to hear Dr. Wojciechowski explain:

results of a study that found the targeted therapy Perjeta increased overall survival by about 1.5 years in women diagnosed with HER2-positive metastatic breast cancer

why wearing a bra IS NOT linked to breast cancer risk

why breastfeeding decreases breast cancer risk

how Trelstar might increase the chances that some premenopausal women get pregnant after going through breast cancer treatment